IBDEI0Q8 ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12890,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,12891,0)
 ;;=710.1^^75^798^19
 ;;^UTILITY(U,$J,358.3,12891,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12891,1,1,0)
 ;;=1^710.1
 ;;^UTILITY(U,$J,358.3,12891,1,2,0)
 ;;=2^SYSTEMIC SCLEROSIS
 ;;^UTILITY(U,$J,358.3,12891,2)
 ;;=^108590
 ;;^UTILITY(U,$J,358.3,12892,0)
 ;;=446.7^^75^798^20
 ;;^UTILITY(U,$J,358.3,12892,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12892,1,1,0)
 ;;=1^446.7
 ;;^UTILITY(U,$J,358.3,12892,1,2,0)
 ;;=2^TAKAYASU'S DISEASE
 ;;^UTILITY(U,$J,358.3,12892,2)
 ;;=^117141
 ;;^UTILITY(U,$J,358.3,12893,0)
 ;;=446.6^^75^798^21
 ;;^UTILITY(U,$J,358.3,12893,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12893,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,12893,1,2,0)
 ;;=2^THROMBOT MICROANGIOPATHY
 ;;^UTILITY(U,$J,358.3,12893,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,12894,0)
 ;;=446.4^^75^798^22
 ;;^UTILITY(U,$J,358.3,12894,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12894,1,1,0)
 ;;=1^446.4
 ;;^UTILITY(U,$J,358.3,12894,1,2,0)
 ;;=2^WEGENER'S GRANULOMATOSIS
 ;;^UTILITY(U,$J,358.3,12894,2)
 ;;=^127623
 ;;^UTILITY(U,$J,358.3,12895,0)
 ;;=444.9^^75^798^9
 ;;^UTILITY(U,$J,358.3,12895,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12895,1,1,0)
 ;;=1^444.9
 ;;^UTILITY(U,$J,358.3,12895,1,2,0)
 ;;=2^OTH ARTERIAL EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,12895,2)
 ;;=^39452
 ;;^UTILITY(U,$J,358.3,12896,0)
 ;;=710.9^^75^798^10
 ;;^UTILITY(U,$J,358.3,12896,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12896,1,1,0)
 ;;=1^710.9
 ;;^UTILITY(U,$J,358.3,12896,1,2,0)
 ;;=2^OTH CONNECTIVE TISSUE DISEASE
 ;;^UTILITY(U,$J,358.3,12896,2)
 ;;=^123811
 ;;^UTILITY(U,$J,358.3,12897,0)
 ;;=453.9^^75^798^11
 ;;^UTILITY(U,$J,358.3,12897,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12897,1,1,0)
 ;;=1^453.9
 ;;^UTILITY(U,$J,358.3,12897,1,2,0)
 ;;=2^OTH VENOUS EMB/THROMBOSIS
 ;;^UTILITY(U,$J,358.3,12897,2)
 ;;=^39455
 ;;^UTILITY(U,$J,358.3,12898,0)
 ;;=441.00^^75^798^1
 ;;^UTILITY(U,$J,358.3,12898,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12898,1,1,0)
 ;;=1^441.00
 ;;^UTILITY(U,$J,358.3,12898,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/ DISSECTION
 ;;^UTILITY(U,$J,358.3,12898,2)
 ;;=^35660
 ;;^UTILITY(U,$J,358.3,12899,0)
 ;;=042.^^75^799^1
 ;;^UTILITY(U,$J,358.3,12899,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12899,1,1,0)
 ;;=1^042.
 ;;^UTILITY(U,$J,358.3,12899,1,2,0)
 ;;=2^AIDS OR HIV INFECTION,SYMPTOMATIC
 ;;^UTILITY(U,$J,358.3,12899,2)
 ;;=^266500
 ;;^UTILITY(U,$J,358.3,12900,0)
 ;;=540.9^^75^799^2
 ;;^UTILITY(U,$J,358.3,12900,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12900,1,1,0)
 ;;=1^540.9
 ;;^UTILITY(U,$J,358.3,12900,1,2,0)
 ;;=2^APPENDICITIS
 ;;^UTILITY(U,$J,358.3,12900,2)
 ;;=^270195
 ;;^UTILITY(U,$J,358.3,12901,0)
 ;;=682.9^^75^799^3
 ;;^UTILITY(U,$J,358.3,12901,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12901,1,1,0)
 ;;=1^682.9
 ;;^UTILITY(U,$J,358.3,12901,1,2,0)
 ;;=2^CELLULITIS AND ABSCESS
 ;;^UTILITY(U,$J,358.3,12901,2)
 ;;=^21160
 ;;^UTILITY(U,$J,358.3,12902,0)
 ;;=576.1^^75^799^4
 ;;^UTILITY(U,$J,358.3,12902,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12902,1,1,0)
 ;;=1^576.1
 ;;^UTILITY(U,$J,358.3,12902,1,2,0)
 ;;=2^CHOLANGITIS
 ;;^UTILITY(U,$J,358.3,12902,2)
 ;;=^23291
 ;;^UTILITY(U,$J,358.3,12903,0)
 ;;=574.70^^75^799^5
 ;;^UTILITY(U,$J,358.3,12903,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12903,1,1,0)
 ;;=1^574.70
 ;;^UTILITY(U,$J,358.3,12903,1,2,0)
 ;;=2^CHOLECYSTITIS
 ;;^UTILITY(U,$J,358.3,12903,2)
 ;;=^304314
 ;;^UTILITY(U,$J,358.3,12904,0)
 ;;=571.5^^75^799^6
 ;;^UTILITY(U,$J,358.3,12904,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12904,1,1,0)
 ;;=1^571.5
